Study guide

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias

NPLEX Part I — Biomedical Sciences Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Pacing, and GEA Strategy

1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards

2 Chapter 2: Gross Anatomy & Musculoskeletal System

2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures

3 Chapter 3: Histology & Microscopic Anatomy

3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium

4 Chapter 4: Neuroanatomy & Special Senses

4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation

5 Chapter 5: Embryology & Developmental Anatomy

5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology

6 Chapter 6: Cellular & General Physiology

6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle

7 Chapter 7: Cardiovascular & Respiratory Physiology

7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing

8 Chapter 8: Renal, Fluid, & Acid-Base Physiology

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology

9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation

10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism

10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport

11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics

11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics

12 Chapter 12: Immunology & Immunopathology

12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types

13 Chapter 13: Medical Microbiology

13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens

14 Chapter 14: General Pathology & Neoplasia

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors

15 Chapter 15: Systems Pathology & Disease Mechanisms

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias

Key Takeaways Explain This Topic AI

Atherosclerosis progresses from endothelial injury and LDL oxidation to foam cell accumulation, fibrous cap formation, and complications such as plaque rupture, acute thrombosis, or abdominal aortic aneurysm.

Myocardial infarction undergoes a predictable histological timeline: early coagulation necrosis (4–24 hours), dense neutrophilic infiltration (1–3 days), macrophage phagocytosis and soft wall vulnerability (3–7 days), granulation tissue formation (1–3 weeks), and dense fibrous scar creation (>2 weeks).

Left-sided heart failure causes pulmonary venous congestion and hemosiderin-laden alveolar macrophages ('heart failure cells'), whereas right-sided heart failure leads to systemic venous congestion, jugular venous distension, and hepatic nutmeg liver appearance.

COPD comprises Chronic Bronchitis (Reid index > 50%, 'blue bloater') and Emphysema (centriacinar smoking-related upper lobe destruction vs. panacinar alpha-1 antitrypsin deficiency lower lobe destruction, 'pink puffer').

Pneumonias present in distinct anatomical patterns: Lobar pneumonia (S. pneumoniae, evolving through 4 stages: congestion, red hepatization, gray hepatization, resolution), Bronchopneumonia (patchy multifocal consolidation), and Interstitial atypical pneumonia (Mycoplasma, viruses).

Last updated: July 2026

  • 14.4 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias
  • 1. Atherosclerosis and Ischemic Heart Disease
  • Pathogenesis of Atherosclerosis

Atherosclerosis is a chronic inflammatory and proliferative response of the arterial wall to endothelial injury. The progression unfolds through six distinct pathological stages:

Endothelial Dysfunction & Injury : Triggered by hemodynamic strain, hyperlipidemia, smoking, or hyperglycemia. Permeability to circulating lipoproteins increases.

LDL Accumulation & Oxidation : Low-density lipoprotein (LDL) enters the subendothelial intima where it undergoes oxidation by reactive oxygen species (ROS). Oxidized LDL (oxLDL) is pro-inflammatory and cytotoxic.

Monocyte Recruitment & Foam Cell Formation : Endothelial cells express adhesion molecules (VCAM-1, ICAM-1). Monocytes migrate into the intima, differentiate into macrophages, and engulf oxLDL via scavenger receptors (CD36, SR-A). Lipid-laden macrophages become foam cells .

Fatty Streak Formation : Aggregations of subendothelial foam cells form visible yellow streaks, the earliest microscopic lesion of atherosclerosis.

Smooth Muscle Cell Migration & Matrix Synthesis : Platelet-derived growth factor (PDGF) and TGF-beta induce vascular smooth muscle cell (VSMC) migration from the media to the intima. VSMCs proliferate and deposit extracellular matrix (collagen, elastin), forming a fibrous cap over a central necrotic core rich in lipids and debris.

Complications : Plaque destabilization occurs via metalloproteinase secretion. Rupture exposes tissue factor, triggering acute thrombosis (causing unstable angina, MI, or stroke). Long-term media erosion causes vessel wall weakening and aneurysm formation (typically abdominal aortic aneurysm).

Ischemic Heart Disease (IHD) Spectrum

Ischemic heart disease results from an imbalance between myocardial oxygen demand and coronary blood supply.

Clinical Entity Pathophysiology EKG & Marker Findings Clinical Presentation

Stable Angina >70% fixed coronary stenosis; exertional ischemia ST depression during exercise; normal cardiac enzymes Subendocardial ischemia; chest pressure relieved by rest/nitroglycerin

Unstable Angina Incomplete/transient plaque rupture with non-occlusive thrombus ST depression or T-wave inversion; normal cardiac enzymes Angina at rest or of increasing frequency/severity

Prinzmetal (Variant) Angina Transient coronary artery vasospasm (hyperreactivity) Transient ST elevation during episode; normal enzymes Episodic chest pain occurring at rest, often in early morning

NSTEMI Subtotal coronary occlusion causing subendocardial infarction ST depression, T-wave inversion; elevated Troponin I/T and CK-MB Severe chest pain; necrosis limited to inner 1/3 to 1/2 of ventricular wall

STEMI Complete transmural coronary artery occlusion ST elevation, Q waves; markedly elevated Troponin I/T and CK-MB Severe crushing retrosternal pain radiating to jaw/left arm; transmural necrosis

Myocardial Infarction: Histological Timeline & Complications

Following acute coronary occlusion, myocardial tissue undergoes a sequential histological evolution:

0–4 Hours : Minimal light microscopic change; electron microscopy reveals wavy myocardial fibers and glycogen depletion.

4–24 Hours : Early coagulation necrosis , contraction band necrosis at edges, hypereosinophilic myocytes, and marginal edema. Risk of fatal ventricular arrhythmias (ventricular fibrillation) is highest.

1–3 Days : Extensive coagulation necrosis with loss of nuclei and cross-striations; dense neutrophilic infiltrate into the interstitium. Pericarditis may manifest as a friction rub.

3–7 Days : Neutrophils undergo apoptosis; macrophage influx phagocytoses necrotic debris. The infarcted wall is soft and structurally fragile.

7–14 Days : Proliferation of granulation tissue with rich capillary networks and collagen deposition at the margins.

2–8 Weeks : Progressive collagenization resulting in a dense, hypocellular fibrous scar .

Critical Post-MI Complications

Free Wall Rupture (Days 3–14) : Macrophage cleavage of necrotic myocardium leads to ventricular rupture, hemopericardium, and cardiac tamponade (Beck's triad: hypotension, muffled heart sounds, JVD).

Papillary Muscle Rupture (Days 3–7) : Ischemia (most commonly posteromedial papillary muscle supplied solely by PDA) causes acute severe mitral regurgitation and sudden pulmonary edema.

Interventricular Septal Rupture (Days 3–5) : Rupture creates a left-to-right shunt causing acute right heart failure and a new harsh holosystolic murmur.

Dressler Syndrome (Weeks 2–8) : Autoimmune pericarditis triggered by anti-myocardial antibodies, presenting with fever, pleuritic chest pain, and pericardial effusion.

  • 2. Heart Failure and Hypertensive Vascular Disease
  • Heart Failure Pathophysiology

Heart failure is a complex clinical syndrome resulting from structural or functional impairment of ventricular filling or ejection of blood.

Left-Sided Heart Failure :

Systolic Failure : Reduced ejection fraction (HFrEF < 40%) caused by impaired myocardial contractility (e.g., post-MI, dilated cardiomyopathy).

Diastolic Failure : Preserved ejection fraction (HFpEF ≥ 50%) caused by impaired ventricular relaxation and decreased compliance (e.g., concentric hypertrophy from chronic HTN).

Manifestations : Left atrial pressure rises, backing up into pulmonary veins. Elevated pulmonary capillary hydrostatic pressure leads to pulmonary congestion and pulmonary edema. Symptoms include dyspnea, orthopnea, paroxysmal nocturnal dyspnea (PND), and S3 gallop. Histology demonstrates hemosiderin-laden alveolar macrophages ("heart failure cells") from extravasated red blood cells.

Right-Sided Heart Failure :

Etiologies : Most commonly secondary to left-sided heart failure. Isolated right heart failure due to intrinsic lung disease or pulmonary vascular disease is termed cor pulmonale .

Manifestations : Systemic venous congestion leads to jugular venous distension (JVD), peripheral pitting edema, and passive congestion of the liver resulting in a nutmeg liver appearance (centrilobular necrosis with fatty peripheral hepatocytes). Severe cases progress to cardiac cirrhosis and ascites.

Hypertensive Vascular Pathology

Hypertension is defined as persistent blood pressure ≥ 130/80 mmHg (Stage 1 ACC/AHA) or ≥ 140/90 mmHg.

Essential (Primary) Hypertension (90–95%) : Multifactorial etiology combining genetic susceptibility, environmental factors (high sodium intake), and sympathetic/RAAS overactivity.

Secondary Hypertension (5–10%) : Identifiable underlying etiologies including renal artery stenosis (fibromuscular dysplasia or atherosclerosis causing activation of RAAS), Conn syndrome (primary hyperaldosteronism), Cushing syndrome, and Pheochromocytoma.

Vascular Morphological Changes :

Hyaline Arteriolosclerosis : Seen in benign essential HTN and diabetes mellitus. Pink, homogeneous hyaline thickening of arteriolar walls due to extravasation of plasma proteins and smooth muscle matrix synthesis, resulting in luminal narrowing and end-organ ischemia (arteriolosclerotic nephrosclerosis).

Hyperplastic Arteriolosclerosis : Characteristic of severe/malignant HTN (BP > 180/120 mmHg). Concentric, laminated "onion-skinning" of smooth muscle cells and basement membrane duplication, often accompanied by fibrinoid necrosis (necrotizing arteriolitis) in kidney arterioles.

  • 3. Pulmonary Pathology: Obstructive, Restrictive, and Infectious
  • Chronic Obstructive Pulmonary Disease (COPD) & Asthma

COPD is characterized by persistent, non-reversible airflow limitation due to loss of elastic recoil or increased airway resistance.

  • Feature Chronic Bronchitis Emphysema Asthma
  • Primary Site Large and small airways Acinus (respiratory bronchioles/alveoli) Bronchi and bronchioles

Pathology Mucous gland hypertrophy ( Reid index > 50% ); goblet cell hyperplasia Alveolar septal destruction; elastase excess over antiprotease (alpha-1 antitrypsin) Smooth muscle hypertrophy, eosinophilic inflammation, basement membrane thickening

Subtypes/Etio Tobacco smoke, air pollutants Centriacinar (smoking, upper lobes) vs Panacinar (AAT deficiency, lower lobes) Atopic (IgE/Type I hypersensitivity) vs Non-atopic (aspirin, exercise)

Clinical Profile "Blue Bloater" : Productive cough > 3 consecutive months for 2 consecutive years; cyanosis, edema "Pink Puffer" : Dyspnea, prolonged expiration, barrel chest, weight loss, minimal cough Episodic wheezing, dyspnea, chest tightness; reversible with beta-agonists

Sputum/Histology Mucopurulent sputum Loss of elastic recoil, enlarged air spaces Curschmann spirals (mucus plugs) and Charcot-Leyden crystals (eosinophil galectin-10)

Restrictive Lung Diseases

Restrictive diseases are characterized by reduced expansion of lung parenchyma and decreased total lung capacity (TLC, FEV1/FVC ratio is normal or increased > 80%).

Idiopathic Pulmonary Fibrosis (IPF) : Repeated epithelial damage and aberrant repair driven by TGF-beta leads to progressive subpleural interstitial fibrosis, fibroblastic foci, and honeycomb lung appearance on CT.

Sarcoidosis : Systemic granulomatous disease characterized by non-caseating granulomas composed of epithelioid histiocytes and multinucleated giant cells containing asteroid bodies and Schaumann bodies . Associated with bilateral hilar lymphadenopathy, elevated serum ACE levels, and hypercalcemia (due to 1-alpha-hydroxylase activation by macrophages).

Pneumoconioses :

Silicosis : Inhalation of silica particles by miners/sandblasters. Macrophage ingestion of silica causes phagolysosome rupture and fibrogenic cytokine release. Forms nodular fibrotic lesions in upper lobes with characteristic eggshell calcifications of hilar lymph nodes. Increases risk of tuberculosis.

Asbestosis : Inhalation of asbestos fibers in roofers/shipbuilders. Pathognomonic ferruginous bodies (golden-brown, dumbbell-shaped asbestos fibers coated with iron and protein). Manifests with parietal pleural thickening, ivory-colored pleural plaques , subpleural interstitial fibrosis (lower lobes), and markedly increased risk of bronchogenic carcinoma and malignant mesothelioma.

Pneumonia Patterns

Pneumonia is an infection of the lung parenchyma categorized by anatomical distribution and etiology:

Lobar Pneumonia : Acute diffuse consolidation of an entire lung lobe, predominantly caused by Streptococcus pneumoniae (90%). Evolves through 4 classic stages:

Congestion (Days 1–2) : Vascular engorgement, intra-alveolar fluid with abundant bacteria, few neutrophils.

Red Hepatization (Days 3–4) : Massive neutrophilic exudation with extravasated erythrocytes filling alveoli; liver-like firm consistency.

Gray Hepatization (Days 5–7) : Disintegration of red blood cells; persistent fibrinopurulent exudate with macrophages.

Resolution (Day 8+) : Enzymatic digestion of exudate by macrophages, restoring normal lung architecture.

Bronchopneumonia : Patchy, multifocal consolidation centered around bronchioles, often bilateral and basal. Common pathogens include Staphylococcus aureus (post-viral), Klebsiella pneumoniae (alcoholics, currant-jelly sputum), Pseudomonas aeruginosa (cystic fibrosis), and Haemophilus influenzae .

Interstitial (Atypical) Pneumonia : Diffuse inflammation confined to alveolar septa without alveolar exudate. Presents with non-productive cough, low fever, and interstitial reticular infiltrates on chest X-ray. Common pathogens include Mycoplasma pneumoniae (cold agglutinins IgM), Chlamydia pneumoniae , Legionella pneumophila , and respiratory viruses (Influenza, RSV, SARS-CoV-2).

Loading diagram... Pathophysiological Cascade of Atherosclerosis and Clinical Sequelae